Home >> Current Pharmaceutical Design, Volume 13, Number 21
Current Pharmaceutical Design logo Bentham Science Publishers logo

Current Pharmaceutical Design publishes timely in-depth reviews covering all aspects of current research in rational drug design. Each issue is devoted to a single major therapeutic area. A Guest Editor who is an acknowledged authority in a therapeutic field has solicits for each issue comprehensive and timely reviews from leading researchers in the pharmaceutical industry and academia.

Each thematic issue of Current Pharmaceutical Design covers all subject areas of major importance to modern drug design, including: medicinal chemistry, pharmacology, drug targets and disease mechanism.

Publisher: Bentham Science Publishers

Related content
Volume 13, Number 21, July 2007

< previous issue | all issues | next issue >

Articles

Src Inhibitors and Angiogenesis
pp. 2118-2128(11)
Authors: S. Schenone,; F. Manetti,; M. Botta,

Targeting Vascular Cell Migration as a Strategy for Blocking Angiogenesis: The Central Role of Focal Adhesion Protein Tyrosine Kinase Family
pp. 2129-2145(17)
Authors: A. Angelucci,; M. Bologna,

Editorial [Hot Topic: New Potential Pharmaceutical Targets of Metabolic Syndrome (Executive Editors: Gianluca Iacobellis and Giuseppe Barbaro)]
pp. 2146-2147(2)
Authors: Gianluca Iacobellis,; Giuseppe Barbaro,

Metabolic Syndrome and Adipose Tissue: New Clinical Aspects and Therapeutic Targets
pp. 2148-2168(21)
Authors: C.V. Iannucci,; D. Capoccia,; M. Calabria,; F. Leonetti,

Visceral and Subcutaneous Adiposity: Are Both Potential Therapeutic Targets for Tackling the Metabolic Syndrome?
pp. 2169-2175(7)
Authors: Amaia Rodriguez,; Victoria Catalan,; Javier Gomez-Ambrosi,; Gema Fruhbeck,

Homo obesus: A Metabotrophin-Deficient Species. Pharmacology and Nutrition Insight
pp. 2176-2179(4)
Authors: G.N. Chaldakov,; M. Fiore,; A.B. Tonchev,; D. Dimitrov,; R. Pancheva,; G. Rancic,; L. Aloe,

Epicardial Adipose Tissue As New Cardio-Metabolic Risk Marker and Potential Therapeutic Target in the Metabolic Syndrome
pp. 2180-2184(5)
Authors: Gianluca Iacobellis,; Arya M. Sharma,

Dual Modulation of Vascular Function by Perivascular Adipose Tissue and Its Potential Correlation with Adiposity/Lipoatrophy-Related Vascular Dysfunction
pp. 2185-2192(8)
Author: Yu-Jing Gao,

Non-Alcoholic Fatty Liver Disease in the Metabolic Syndrome
pp. 2193-2198(6)
Authors: Giuseppe Palasciano,; Antonio Moschetta,; Vincenzo O. Palmieri,; Ignazio Grattagliano,; Gianluca Iacobellis,; Piero Portincasa,

Targeting the Liver in the Metabolic Syndrome: Evidence from Animal Models
pp. 2199-2207(9)
Authors: Michele Petruzzelli,; Giuseppe Lo Sasso,; Piero Portincasa,; Giuseppe Palasciano,; Antonio Moschetta,

Visceral Fat as Target of Highly Active Antiretroviral Therapy-Associated Metabolic Syndrome
pp. 2208-2213(6)
Author: Giuseppe Barbaro,

< previous issue | all issues | next issue >

Marked list

Key

Free Content
Free content
New Content
New content
Open Access Content
Open access content
Subscribed Content
Subscribed content
Free Trial Content
Free trial content

Text size:

A | A | A | A
^ Back to top
Share this item with others: These icons link to social bookmarking sites where readers can share and discover new web pages. print icon Print this page